Beth Israel Deaconess Medical Center Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Beth Israel Deaconess Medical Center Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011920
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Beth Israel Deaconess Medical Center Inc (BIDMC), a subsidiary of CareGroup Inc is a healthcare center that offers clinical care, biomedical research and education, health and wellness services. The center offers patient and family care services such as admitting, case management, ethics support, nursing, nutritional services and volunteer services, among others. It offers biomedical research programs which include vascular and transplantation research, signal transduction and molecular imaging services. The center offers treatment in therapeutic areas of cardiology, obstetrics, gastrointestinal disorders and cancer care. It operates healthcare centers in Milton, Needham, Plymouth, Chelsea and Lexington. BIDMC is headquartered in Boston, Massachusetts, the US.

Beth Israel Deaconess Medical Center Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Beth Israel Deaconess Medical Center Inc, Medical Devices Deals, 2011 to YTD 2017 9
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Mustang Bio Enters into Agreement with Beth Israel Deaconess 11
Genus Oncology Partners with Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center 12
CureMeta Enters into Research Agreement with Beth Israel Deaconess Medical Center 13
Jackson Lab Enters into Co-Development Agreement with Beth Israel Deaconess Medical Center 14
Licensing Agreements 15
Acceleron Pharma Enters into Licensing Agreement with Beth Israel Deaconess Medical Center 15
Acquisition 16
Beth Israel Deaconess Medical Center Finalizes Acquisition Of Jordan Health Systems 16
Beth Israel Deaconess Medical Center Inc – Key Competitors 17
Beth Israel Deaconess Medical Center Inc – Key Employees 18
Beth Israel Deaconess Medical Center Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 20
Recent Developments 21
Government and Public Interest 21
Dec 04, 2017: Study Finds More Than 1 in 6 Patients With Peripheral Arterial Disease Who Undergo Revascularization Readmitted Within 30 Days 21
Dec 16, 2016: Research Team Led by BIDMC’s Robert Gerszten, MD, Receives $11 Million NIH Grant to Study Molecular Changes Linked to Exercise and Physical Activity 23
Apr 18, 2016: Newly Discovered Vulnerability in Breast Tumor Cells Points to Novel Treatment Approach Against Cancer 24
Apr 13, 2016: Researchers Uncover Earliest Events Following HIV Infection, Before Virus Is Detectable 25
Mar 31, 2016: New study implicates unusual class of circular RNAs in cancer 26
Mar 28, 2016: BIDMC Researchers Discover Early Indicators of Pancreatic Cancer 28
Mar 16, 2016: Mitochondrial Metabolism Linked to Acute Kidney Injury 29
Feb 15, 2016: Genetic variation shown in patients with severe vascular complications of infection 31
Jan 28, 2016: New Insights into PI3K Pathway and Cancer Metabolism 32
Product News 34
Nov 09, 2016: New Therapeutic Vaccine Approach Holds Promise for HIV Remission 34
Jul 27, 2016: New Proteomics Tool Reveals Novel Biomarkers for Cardiovascular Risk 36
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare, Key Facts 2
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Beth Israel Deaconess Medical Center Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Beth Israel Deaconess Medical Center Inc, Medical Devices Deals, 2011 to YTD 2017 9
Beth Israel Deaconess Medical Center Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Mustang Bio Enters into Agreement with Beth Israel Deaconess 11
Genus Oncology Partners with Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center 12
CureMeta Enters into Research Agreement with Beth Israel Deaconess Medical Center 13
Jackson Lab Enters into Co-Development Agreement with Beth Israel Deaconess Medical Center 14
Acceleron Pharma Enters into Licensing Agreement with Beth Israel Deaconess Medical Center 15
Beth Israel Deaconess Medical Center Finalizes Acquisition Of Jordan Health Systems 16
Beth Israel Deaconess Medical Center Inc, Key Competitors 17
Beth Israel Deaconess Medical Center Inc, Key Employees 18
Beth Israel Deaconess Medical Center Inc, Subsidiaries 20
Beth Israel Deaconess Medical Center Inc, Joint Venture 20

★海外企業調査レポート[Beth Israel Deaconess Medical Center Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wns (Holdings) Limited:企業の戦略・SWOT・財務分析
    Wns (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary Wns (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • WPP plc:企業の戦略・SWOT・財務情報
    WPP plc - Strategy, SWOT and Corporate Finance Report Summary WPP plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Curetis NV (CURE):企業の財務・戦略的SWOT分析
    Summary Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company provides diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for cartridges, diseases such as implant and tissue inf …
  • Celonic AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Celonic AG (Celonic), a subsidiary of JRS Pharma LP is a biotechnology company that offers contract development manufacturing organization services. The company’s services include development of cell lines and biotechnological production processes, full GMP analytics, and manufacture of acti …
  • Technogenetics srl:医療機器:M&Aディール及び事業提携情報
    Summary Technogenetics srl (Technogenetics), a subsidiary of Shanghai Kehua Bio-engineering Co Ltd, is an immunodiagnostics and molecular genetics company that offers reagents and instruments in the field of biotechnology and pharmacology. The company provides immunodiagnostics products in the areas …
  • Intertek Group Plc (ITRK):石油・ガス:M&Aディール及び事業提携情報
    Summary Intertek Group Plc (Intertek) is a provider of quality and safety solutions to various businesses across the globe. It offers services such as testing, inspection, certification, auditing, advisory services, quality assurance, consulting, sourcing, hazardous substance testing, analytical ass …
  • TDC A/S:企業の戦略・SWOT・財務分析
    TDC A/S - Strategy, SWOT and Corporate Finance Report Summary TDC A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • DeepOcean Group Holding BV:企業の戦略的SWOT分析
    DeepOcean Group Holding BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • United Cooperative Services, Inc.:企業の戦略的SWOT分析
    United Cooperative Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • CardioGenics Inc:企業の製品パイプライン分析2018
    Summary CardioGenics Inc (CardioGenics), a subsidiary of CardioGenics Holdings Inc is a medical device company that manufactures sensitive diagnostic test products to the in-vitro diagnostics market. The company’s products include QL care analyzer, immunoassay tests, and paramagnetic beads, among ot …
  • TransMontaigne Product Services LLC:企業の戦略的SWOT分析
    TransMontaigne Product Services LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Flatiron Health Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Flatiron Health Inc (Flatiron Health) a subsidiary of F. Hoffmann-La Roche Ltd, is a healthcare technology company which develops a learning healthcare system in oncology. The company offers a web-based business and clinical intelligence data platform that integrates and structures disparate …
  • Sunkist Growers, Inc.:企業の戦略的SWOT分析
    Sunkist Growers, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Identiv Inc (INVE):企業の財務・戦略的SWOT分析
    Summary Identiv Inc (Identiv), formerly Identive Group Inc, is a technology company that offers physical security and secure identification solutions. The company’s products include trusted authentication solutions, identity solutions, physical access control solutions, premises access solutions, co …
  • Msig Holdings (Asia) Pte. Ltd.
    Msig Holdings (Asia) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Msig Holdings (Asia) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Michigan Public Power Agency:企業の戦略的SWOT分析
    Michigan Public Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • TBG Diagnostics Ltd (TDL):医療機器:M&Aディール及び事業提携情報
    Summary TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is a molecular diagnostics company that develops, manufactures and markets molecular diagnostics kits, instruments and services. The company’s major products include nucleic acid extraction kits, HLA SBT typing kits, …
  • Energisa SA (ENGI11):電力:M&Aディール及び事業提携情報
    Summary Energisa SA (Energisa) is a power utility that generates, distributes and sells electricity. The company generates electricity through wind, small hydropower, and biomass resources. It also operates and maintains hydroelectric power plants for other companies; constructs and refurbishes gene …
  • Nymox Pharmaceutical Corp (NYMX):企業の財務・戦略的SWOT分析
    Nymox Pharmaceutical Corp (NYMX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • CorMedix Inc (CRMD):製薬・医療:M&Aディール及び事業提携情報
    Summary CorMedix Inc (CorMedix) is a commercial-stage pharmaceutical company that develops and commercializes therapeutic products for prevention and treatment of cardiac, renal and infectious diseases. The company offers neutrolin, a non-antibiotic anti-infective developed as a preventative solutio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆